U.S. Markets closed

Celgene Told To Divest Blockbuster Drug — And Other Bad News For Bristol

ALLISON GATLIN
Celgene Told To Divest Blockbuster Drug — And Other Bad News For Bristol

Celgene will have to divest its blockbuster drug Otezla in order to satisfy drug regulators before completing its merger with Bristol-Myers Squibb, the biopharma company said Monday.